Oramed Pharmaceuticals Inc (ORMP)
2.33
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 16:00
2.33
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Total Liabilities (Quarterly): 8.069M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 8.069M |
March 31, 2024 | 37.93M |
December 31, 2023 | 57.66M |
September 30, 2023 | 82.66M |
June 30, 2023 | 5.659M |
March 31, 2023 | 9.632M |
December 31, 2022 | 10.49M |
September 30, 2022 | 11.29M |
June 30, 2022 | 9.254M |
March 31, 2022 | 10.00M |
November 30, 2021 | 11.76M |
August 31, 2021 | 11.48M |
May 31, 2021 | 11.30M |
February 28, 2021 | 12.22M |
November 30, 2020 | 12.76M |
August 31, 2020 | 11.75M |
May 31, 2020 | 12.04M |
February 29, 2020 | 13.79M |
November 30, 2019 | 13.98M |
August 31, 2019 | 15.27M |
May 31, 2019 | 15.88M |
February 28, 2019 | 16.46M |
November 30, 2018 | 14.74M |
August 31, 2018 | 16.28M |
May 31, 2018 | 18.00M |
Date | Value |
---|---|
February 28, 2018 | 17.77M |
November 30, 2017 | 18.80M |
August 31, 2017 | 19.47M |
May 31, 2017 | 19.98M |
February 28, 2017 | 20.51M |
November 30, 2016 | 20.94M |
August 31, 2016 | 16.64M |
May 31, 2016 | 5.322M |
February 29, 2016 | 5.667M |
November 30, 2015 | 1.342M |
August 31, 2015 | 1.526M |
May 31, 2015 | 0.802M |
February 28, 2015 | 0.641M |
November 30, 2014 | 0.863M |
August 31, 2014 | 1.009M |
May 31, 2014 | 0.527M |
February 28, 2014 | 0.3822M |
November 30, 2013 | 0.7004M |
August 31, 2013 | 0.529M |
May 31, 2013 | 0.6871M |
February 28, 2013 | 0.7093M |
November 30, 2012 | 0.575M |
August 31, 2012 | 1.517M |
May 31, 2012 | 0.5027M |
February 29, 2012 | 0.7442M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.659M
Minimum
Jun 2023
82.66M
Maximum
Sep 2023
18.62M
Average
11.75M
Median
Aug 2020
Total Liabilities (Quarterly) Benchmarks
Skye Bioscience Inc | 14.45M |
Scilex Holding Co | 319.24M |
NovaBay Pharmaceuticals Inc | 4.542M |
Palatin Technologies Inc | 10.85M |
iBio Inc | 7.41M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 184.22M |
Shareholders Equity (Quarterly) | 177.06M |